← Back to Patent Explorer
US4004012A Expired / Lapsed US ⏱️ 0.0 years remaining

3-Cyano-5-(pyridinyl)-2(1H)-pyridinones

Assignee: STWB Inc
•
Filing: 1975-10-14
•
Granted: 1977-01-18
•
Expires: 1995-10-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds useful as cardiotonic agents are 1-R-3-Q-5-PY-2(1H)-pyridinones (I) where R is hydrogen, loweralkyl or lower-hydroxyalkyl, Q is amino (preferred) or NHAc, Ac is lower-alkanoyl or lower-carbalkoxy, and PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents. The corresponding compounds where Q is nitro, carbamyl, cyano or hydrogen are useful as intermediates and those where Q is hydrogen or cyano also are useful as cardiotonic agents. Said compounds are prepared: by reacting α-PY-β-(R 1 R 2 N)acrolein (II) with malonamide to produce 1,2-dihydro-2-oxo-5-PY-nicotinamide (Ia) and reacting Ia with a reagent capable of converting carbamyl to amino to produce 3-amino-5-PY-2(1H)-pyridone (Ib); by reacting II or α-PY-malonaldehyde (II') with α-cyanoacetamide to produce 1,2-dihydro-2-oxo-5-PY-nicotinonitrile (III) and partially hydrolyzing III to produce Ia; and, by heating 1,2-dihydro-2-oxo-5-PY-nicotinic acid (IV) with a mixture of concentrated sulfuric acid and concentrated nitric acid to produce 3-nitro-5-PY-2(1H)-pyridinone (Ic) and then either reducing Ic to produce Ib or first reacting Ic with an alkylating agent to produce 1-R'-3-nitro-5-PY-2(1H)-pyridinone (Id) and reducing Id to produce 1-R'-3-amino-5-PY-2(1H)-pyridinone (Ib) where R' is lower-alkyl or lower-hydroxyalkyl.

Inventors

  • 👤 George Y. Lesher
  • 👤 Chester Joseph Opalka

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 11:30
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/44; C07D213/53; C07D213/36; C07D213/38; C07D213/46; C07D213/48; C07D213/60; C07D213/62; C07D213/63; C07D213/64; C07D213/72; C07D213/73; C07D213/74; C07D213/75; C07D213/78; C07D213/79; C07D213/80; C07D213/81; C07D213/82; C07D213/84; C07D213/85

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 55 words
A 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula ##STR3##where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl having from two to six carbon atoms and having its hydroxy group and free valence bond on different carbon atoms an Q is cyano.
Claim 2
Dependent Claim 55 words
A 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula ##STR3##where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl having from two to six carbon atoms and having its hydroxy group and free valence bond on different carbon atoms an Q is cyano.
Claim 3
Dependent Claim 14 words
A compound according to claim 1 where R is hydrogen and Q is cyano.
Claim 4
Dependent Claim 5 words
1,2-Dihydro-2-oxo-5-(4-pyridinyl)nicotinonitrile according to claim 2.
Claim 5
Dependent Claim 79 words
A cardiotonic composition for increasing cardiac contractility, said composition comprising a pharmaceutically-acceptable inert carrier and, as the active component thereof, an effective amount of a cardiotonic 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula ##STR4##where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl having from two to six carbon atoms and having its hydroxy group and free valence bond on different carbon atoms Q is cyano.
Claim 6
Dependent Claim 79 words
A cardiotonic composition for increasing cardiac contractility, said composition comprising a pharmaceutically-acceptable inert carrier and, as the active component thereof, an effective amount of a cardiotonic 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula ##STR4##where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl having from two to six carbon atoms and having its hydroxy group and free valence bond on different carbon atoms Q is cyano.
Claim 7
Independent Claim 78 words
The method for increasing cardiac contractility in a patient requiring such treatment which comprises administering to such patient an effective amount of a cardiotonic 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula ##STR5##where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl having from two to six carbon atoms and having its hydroxy group and free valence bond on different carbon atoms and Q is cyano.
Claim 8
Independent Claim 78 words
The method for increasing cardiac contractility in a patient requiring such treatment which comprises administering to such patient an effective amount of a cardiotonic 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula ##STR5##where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl having from two to six carbon atoms and having its hydroxy group and free valence bond on different carbon atoms and Q is cyano.

References Cited (Backward Citations)

US3814771A Cited
US3853896A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-01-18 1980-07-19 1981-01-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-01-18 1984-07-19 1985-01-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-01-18 1988-07-19 1989-01-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag